Based on the above studies, we concluded that the protective effects ofGLP-1-reversing hepatic steatosis are dependent on inhibition of FTO gene expressionvia the PI3K signaling pathway, resulting in subsequent changes in oxidative stressbiomarkers. The gene discussed is FTO; the disease is fatty liver disease.